{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:14:00Z","timestamp":1789204440073,"version":"build-2803163510"},"reference-count":101,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Society of Clinical Oncology Educational Book"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>Breast cancer is the second most common primary tumor associated with central nervous system (CNS) metastases. Patients with metastatic HER2-positive or triple-negative (estrogen receptor (ER)\u2013negative, progesterone receptor (PR)\u2013negative, HER2-negative) breast cancer are at the highest risk of developing parenchymal brain metastases. Leptomeningeal disease is less frequent but is distributed across breast cancer subtypes, including lobular breast cancer. Initial treatment strategies can include surgery, radiation, intravenous or intrathecal chemotherapy, and\/or targeted approaches. In this article, we review the epidemiology of breast cancer brain metastases, differences in clinical behavior and natural history by tumor subtype, and important considerations in the multidisciplinary treatment of these patients. We will highlight new findings that impact current standards of care, clinical controversies, and notable investigational approaches in clinical testing.<\/jats:p>","DOI":"10.1200\/edbk_175338","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T13:53:53Z","timestamp":1540821233000},"page":"45-56","source":"Crossref","is-referenced-by-count":44,"title":["Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management"],"prefix":"10.1200","author":[{"given":"Nancy U.","family":"Lin","sequence":"first","affiliation":[{"name":"From the Breast Oncology Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO; Department of Neuro-Oncology, University of Turin and City of Health and Science Hospital, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie E.","family":"Gaspar","sequence":"additional","affiliation":[{"name":"From the Breast Oncology Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO; Department of Neuro-Oncology, University of Turin and City of Health and Science Hospital, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Soffietti","sequence":"additional","affiliation":[{"name":"From the Breast Oncology Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO; Department of Neuro-Oncology, University of Turin and City of Health and Science Hospital, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"bibr1-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.149"},{"key":"bibr2-EDBK_175338","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-012-2243-x","volume":"136","author":"Arvold ND","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"bibr3-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23930"},{"key":"bibr4-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70017-2"},{"key":"bibr5-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9820"},{"key":"bibr6-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.6314"},{"key":"bibr7-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1083-9"},{"key":"bibr8-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0527"},{"key":"bibr9-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002223220802"},{"key":"bibr10-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330605"},{"key":"bibr11-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X"},{"key":"bibr12-EDBK_175338","author":"Soffietti R","year":"2017","journal-title":"Neuro-oncol"},{"key":"bibr13-EDBK_175338","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1021262218151","volume":"61","author":"Pollock BE","year":"2003","journal-title":"J Neurooncol"},{"key":"bibr14-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6235"},{"key":"bibr15-EDBK_175338","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00701-015-2479-4","volume":"157","author":"Kamp MA","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"key":"bibr16-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.3171\/2014.9.JNS13939"},{"key":"bibr17-EDBK_175338","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3171\/JNS\/2008\/108\/2\/0248","volume":"108","author":"Suki D","year":"2008","journal-title":"J Neurosurg"},{"key":"bibr18-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.17.1485"},{"key":"bibr19-EDBK_175338","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ijrobp.2016.09.045","volume":"96","author":"Brown PD","year":"2016","journal-title":"Int\u00a0J\u00a0Radiat Oncol Biol Phys"},{"key":"bibr20-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.21.2483"},{"key":"bibr21-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70263-3"},{"key":"bibr22-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.0639"},{"key":"bibr23-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.1655"},{"key":"bibr24-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.10.024"},{"key":"bibr25-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2011.12.004"},{"key":"bibr26-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.6.789"},{"key":"bibr27-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.03.048"},{"key":"bibr28-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9839"},{"key":"bibr29-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not114"},{"key":"bibr30-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.4508"},{"key":"bibr31-EDBK_175338","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/CCO.0b013e3283571a8e","volume":"24","author":"Gibson E","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"bibr32-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2010.09.013"},{"key":"bibr33-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.2909"},{"key":"bibr34-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.4367"},{"key":"bibr35-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.05.015"},{"key":"bibr36-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141438"},{"key":"bibr37-EDBK_175338","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/neuonc\/nov301","volume":"18","author":"Hatzoglou V","year":"2016","journal-title":"Neuro-oncol"},{"key":"bibr38-EDBK_175338","author":"Wagner S","journal-title":"Neuro-oncol"},{"key":"bibr39-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not085"},{"key":"bibr40-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70057-4"},{"key":"bibr41-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00088-1"},{"key":"bibr42-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22127"},{"key":"bibr43-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9409-0"},{"key":"bibr44-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860815)58:4<832::AID-CNCR2820580404>3.0.CO;2-W"},{"key":"bibr45-EDBK_175338","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00280-005-0001-z","volume":"57","author":"Caraglia M","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"bibr46-EDBK_175338","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11060-014-1378-5","volume":"117","author":"Linot B","year":"2014","journal-title":"J Neurooncol"},{"key":"bibr47-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1599::AID-CNCR23>3.0.CO;2-#"},{"key":"bibr48-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.3109\/07357909009012049"},{"key":"bibr49-EDBK_175338","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-004-9176-0","volume":"71","author":"Christodoulou C","year":"2005","journal-title":"J Neurooncol"},{"key":"bibr50-EDBK_175338","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10549-014-3039-y","volume":"146","author":"Anders C","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"bibr51-EDBK_175338","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/annonc\/mdl056","volume":"17","author":"Trudeau ME","year":"2006","journal-title":"Ann Oncol"},{"key":"bibr52-EDBK_175338","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1008354323167","volume":"12","author":"Christodoulou C","year":"2001","journal-title":"Ann Oncol"},{"key":"bibr53-EDBK_175338","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1012226718323","volume":"53","author":"Abrey LE","year":"2001","journal-title":"J Neurooncol"},{"key":"bibr54-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp343"},{"key":"bibr55-EDBK_175338","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11060-007-9491-3","volume":"87","author":"Iwamoto FM","year":"2008","journal-title":"J Neurooncol"},{"key":"bibr56-EDBK_175338","unstructured":"Tutt A, Ellis P, Kilburn L, et al. The TNT trial: a randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA 1\/2 breast cancer (CRUK\/07\/012). Presented at: San Antonio Breast Cancer Symposium. San Antonio, TX; 2014. Abstract S3-01."},{"key":"bibr57-EDBK_175338","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjc.1991.147","volume":"63","author":"Lien EA","year":"1991","journal-title":"Br J Cancer"},{"key":"bibr58-EDBK_175338","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00146879","volume":"10","author":"Pors H","year":"1991","journal-title":"J Neurooncol"},{"key":"bibr59-EDBK_175338","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.breast.2005.07.006","volume":"15","author":"Madhup R","year":"2006","journal-title":"Breast"},{"key":"bibr60-EDBK_175338","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1524-4741.2009.00756.x","volume":"15","author":"Ito K","year":"2009","journal-title":"Breast J"},{"key":"bibr61-EDBK_175338","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s12885-015-1672-4","volume":"15","author":"Adkins CE","year":"2015","journal-title":"BMC Cancer"},{"key":"bibr62-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00332-0"},{"key":"bibr63-EDBK_175338","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s11095-009-9964-5","volume":"26","author":"Thomas FC","year":"2009","journal-title":"Pharm Res"},{"key":"bibr64-EDBK_175338","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-016-3972-z","volume":"160","author":"O\u2019Sullivan CC","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"bibr65-EDBK_175338","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.2004","volume":"34","author":"Kumthekar P","year":"2016","journal-title":"J Clin Oncol"},{"key":"bibr66-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1080"},{"key":"bibr67-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-011-0629-y"},{"key":"bibr68-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605586"},{"key":"bibr69-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq434"},{"key":"bibr70-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70432-1"},{"key":"bibr71-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.0343"},{"key":"bibr72-EDBK_175338","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S1470-2045(15)00373-3","volume":"16","author":"Cort\u00e9s J","year":"2015","journal-title":"Lancet Oncol"},{"key":"bibr73-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00540-9"},{"key":"bibr74-EDBK_175338","volume":"32","author":"Metzger O","year":"2016","journal-title":"J Clin Oncol"},{"key":"bibr75-EDBK_175338","doi-asserted-by":"crossref","unstructured":"Hamilton E, Borges VF, Conlin A, et al. Efficacy results of a phase 1b study of tucatinib (ONT-380), an oral HER2-specific inhibitor, in combination with capecitabine and trastuzumab in HER2+ metastatic breast cancer, including patients with brain metastases. Presented at: San Antonio Breast Cancer Symposium. San Antonio, TX; 2016. Abstract P4-21-01.","DOI":"10.1158\/1538-7445.SABCS16-P4-21-01"},{"key":"bibr76-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.12"},{"key":"bibr77-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1257-5"},{"key":"bibr78-EDBK_175338","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-016-3828-6","volume":"157","author":"Jacot W","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"bibr79-EDBK_175338","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ctrc.2016.03.005","volume":"7","author":"Keith KC","year":"2016","journal-title":"Cancer Treat Commun"},{"key":"bibr80-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu486"},{"key":"bibr81-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.0955"},{"key":"bibr82-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609709"},{"key":"bibr83-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505270"},{"key":"bibr84-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607303"},{"key":"bibr85-EDBK_175338","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000447284","volume":"11","author":"Barroso-Sousa R","year":"2016","journal-title":"Breast Care (Basel)"},{"key":"bibr86-EDBK_175338","volume":"34","author":"Sahebjam S","year":"2016","journal-title":"J Clin Oncol"},{"key":"bibr87-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60892-6"},{"key":"bibr88-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-3039"},{"key":"bibr89-EDBK_175338","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.3944","volume":"21","author":"Kroemer G","year":"2015","journal-title":"Nat Med"},{"key":"bibr90-EDBK_175338","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1470-2045(16)30631-3","volume":"18","author":"Luen SJ","year":"2017","journal-title":"Lancet Oncol"},{"key":"bibr91-EDBK_175338","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-016-0702-8","volume":"18","author":"Duchnowska R","year":"2016","journal-title":"Breast Cancer Res"},{"key":"bibr92-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30053-5"},{"key":"bibr93-EDBK_175338","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","volume":"17","author":"Morikawa A","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"bibr94-EDBK_175338","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11060-011-0592-7","volume":"105","author":"Le Rhun E","year":"2011","journal-title":"J Neurooncol"},{"key":"bibr95-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou089"},{"key":"bibr96-EDBK_175338","author":"Chamberlain M","journal-title":"Neuro-oncol"},{"key":"bibr97-EDBK_175338","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.04.016"},{"key":"bibr98-EDBK_175338","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/bjoc.2000.1574","volume":"84","author":"Jaeckle KA","year":"2001","journal-title":"Br J Cancer"},{"key":"bibr99-EDBK_175338","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","volume":"50","author":"Mason WP","year":"1998","journal-title":"Neurology"},{"key":"bibr100-EDBK_175338","first-page":"3394","volume":"5","author":"Glantz MJ","year":"1999","journal-title":"Clin Cancer Res"},{"key":"bibr101-EDBK_175338","doi-asserted-by":"crossref","unstructured":"Raizer J, Pentsova E, Omuro A, et al. Phase I trial of intrathecal trastzuumab in HER2 positive leptomeningeal metastases. Presented at: 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Miami, FL; 2014. Abstract AT-47.","DOI":"10.1093\/neuonc\/nou237.46"}],"container-title":["American Society of Clinical Oncology Educational Book"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/EDBK_175338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T05:03:53Z","timestamp":1653800633000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/EDBK_175338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":101,"aliases":["10.14694\/edbk_175338"],"journal-issue":{"issue":"37","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1200\/EDBK_175338"],"URL":"https:\/\/doi.org\/10.1200\/edbk_175338","relation":{},"ISSN":["1548-8748","1548-8756"],"issn-type":[{"value":"1548-8748","type":"print"},{"value":"1548-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}